Expression of amino acid receptors and neural peptides in the weaver mouse brain

Brain Research
K FragioudakiAdamantia Mitsacos

Abstract

In the present study, we conducted: (i) in situ hybridization in order to investigate the expression of kainate and GABA(A) receptor subunits and the pre-proenkephalin and prodynorphin peptides in the brain of weaver mouse (a genetic model of dopamine deficiency) and (ii) immunocytochemistry in order to study the somatostatin-positive cells in weaver striatum. Our results indicated: (i) increases in mRNA levels of KA2 and GluR6 kainate receptor subunits, of alpha(4) and beta(3) GABA(A) receptor subunits and of pre-proenkephalin and prodynorphin in 6-month-old weaver striatum; (ii) a decrease in alpha(1) and beta(2) GABA(A) subunit mRNAs in 6-month-old weaver globus pallidus; (iii) increases in KA2, alpha(4) and beta(3) and decreases in alpha(2) and beta(2) mRNAs in the 6-month-old weaver somatosensory cortex; and (iv) an increase in somatostatin-immunopositive cells in 3-month-old weaver striatum. We suggest that: (i) in striatum, the alterations are induced by the induction of the transcription factor DeltafosB (for GluR6, pre-proenkephalin and prodynorphin mRNAs) and the suppression of transcription factors like NGF-IB (nerve growth factor inducible B; for the KA2 mRNA), in response to dopamine depletion; (ii) in striatum and...Continue Reading

References

May 1, 1992·Journal of Neurochemistry·B K Yamamoto, S Davy
Jun 1, 1992·Current Opinion in Neurobiology·W Wisden, P H Seeburg
Nov 1, 1991·The Journal of Physiology·Z G Jiang, R A North
Mar 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·D M WeinerM R Brann
Oct 23, 1990·European Journal of Pharmacology·A ImperatoL Angelucci
Jan 1, 1985·Neuroscience and Biobehavioral Reviews·P W Kalivas
Jan 1, 1988·Experimental Brain Research·L C TriarhouB Ghetti
Jun 1, 1988·The Journal of Physiology·E CherubiniP Stanzione
Oct 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·C CepedaM S Levine
Jan 1, 1995·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·A EspinoM A Navarro
Jul 1, 1997·Brain Research. Molecular Brain Research·D J Healy, J H Meador-Woodruff
Nov 5, 1997·Pharmacology, Biochemistry, and Behavior·D Feifel, K L Minor

❮ Previous
Next ❯

Citations

Mar 6, 2009·Journal of Neural Transmission·Konstantinos SpiliopoulosAda Mitsacos
Aug 26, 2016·The Journal of Comparative Neurology·Minela HadzicPetra Wahle

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Barrel cortex

Here is the latest research on barrel cortex, a region of somatosensory and motor corticies in the brain, which are used by animals that rely on whiskers for world exploration.

Basal ganglia in Parkinson's disease (MDS)

The basal ganglia is comprised of the neostriatum, the external and internal pallidal segments, the subthalamic nucleus, the substantia nigra pars reticulata, and the pars compacta of the substantia nigra. The basal ganglia circuitry is responsible for the correct execution of voluntary movements and is implicated in Parkinson's disease. Here is the latest research investigating the basal ganglia in Parkinson's disease.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here